임상 한눈에 보기

• 14건의 ClinicalTrials.gov 임상 기록
• Phase·Status 요약은 enrollment 상위 표본 기준입니다
• 임상시험 탭에서 enrollment 상위 목록을 불러올 수 있습니다
• Phase: Phase 3 · Phase 2 · Phase 1, Phase 2 · Phase 4
• Status: Completed · Active, not recruiting · Terminated
• 주요 endpoint: Sepsis-related toxicity of antibody-drug conjugate. · Causality assessment of reported cardiovascular events according to the WHO system · Description of the type of sepsis-related toxicities depending on the category of ADC · Description of the drug-drug interactions associated with sepsis-related adverse events · Description of the population of patients having a sepsis-related adverse events
• 등록된 결과: ORR 23.8%
• 핵심: A Single arm, Multicenter, International Trial of Tisotumab Vedotin (HuMax®-TF-ADC) in Previously Treated, Recurrent or …

임상시험이 많습니다. 임상시험 탭에서 Phase/Status 필터·검색을 사용하세요.

수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다.